Literature DB >> 16707911

Effects of growth hormone substitution therapy on cognitive functioning in growth hormone deficient patients: a functional MRI study.

Lucia I Arwert1, Dick J Veltman, Jan Berend Deijen, P Sytze van Dam, Madeleine L Drent.   

Abstract

Patients with childhood-onset growth hormone (GH) deficiency (GHD) show impairments in mood and cognitive functioning which may resolve following GH substitution. Brain functional magnetic resonance imaging (fMRI) during performance of a memory task was used to assess the cerebral activity of such patients. Thirteen childhood-onset GHD patients (mean age 27.3 +/- 6.9 years) were included in a double-blind, placebo-controlled study. The effects of 6 months of GH replacement or placebo therapy were studied using neuropsychological tests and fMRI. One patient was excluded from the study due to noncompliance with the protocol. Six months of GH substitution in these GHD patients resulted in improved memory functioning, both for long-term and working memory. fMRI showed activations during the working memory task in prefrontal, parietal, motor, and occipital cortices, as well as in the right thalamus and anterior cingulate cortex. Decreased activation in the ventrolateral prefrontal cortex was observed after GH treatment as compared with placebo treatment, indicating decreased effort and more efficient recruitment of the neural system involved. It can be concluded that GH treatment for 6 months improved the long-term as well as the working memory in patients with GHD, and this was associated with decreased brain activation in the ventrolateral prefrontal cortex. GH substitution in GHD patients is beneficial for cognitive functioning, the effects of which can be visualized by means of neuroimaging. 2006 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16707911     DOI: 10.1159/000093337

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  24 in total

1.  Neuropsychological functioning in acromegaly: towards identification of modifiable factors to improve long-term care after remission.

Authors:  Alberto M Pereira
Journal:  Endocrine       Date:  2015-09-08       Impact factor: 3.633

2.  Circulating IGF1 regulates hippocampal IGF1 levels and brain gene expression during adolescence.

Authors:  Han Yan; Matthew Mitschelen; Georgina V Bixler; Robert M Brucklacher; Julie A Farley; Song Han; Willard M Freeman; William E Sonntag
Journal:  J Endocrinol       Date:  2011-07-12       Impact factor: 4.286

Review 3.  Management of obesity in the elderly: too much and too late?

Authors:  R L Kennedy; U Malabu; M Kazi; V Shahsidhar
Journal:  J Nutr Health Aging       Date:  2008-11       Impact factor: 4.075

Review 4.  Aging, synaptic dysfunction, and insulin-like growth factor (IGF)-1.

Authors:  Ferenc Deak; William E Sonntag
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-04-12       Impact factor: 6.053

Review 5.  Growth hormone and cognitive function.

Authors:  Fred Nyberg; Mathias Hallberg
Journal:  Nat Rev Endocrinol       Date:  2013-04-30       Impact factor: 43.330

6.  Growth patterns and the use of growth hormone in the mucopolysaccharidoses.

Authors:  L E Polgreen; B S Miller
Journal:  J Pediatr Rehabil Med       Date:  2010

7.  Neuropsychological recovery and quality-of-life in children and adolescents with growth hormone deficiency following TBI: a preliminary study.

Authors:  Julia B Wamstad; Kenneth W Norwood; Alan D Rogol; Matthew J Gurka; Mark D Deboer; James A Blackman; Marcia L Buck; Michelle N Kuperminc; Jodi G Darring; Peter D Patrick
Journal:  Brain Inj       Date:  2013       Impact factor: 2.311

8.  The Ames dwarf mutation attenuates Alzheimer's disease phenotype of APP/PS1 mice.

Authors:  Kendra L Puig; Joshua A Kulas; Whitney Franklin; Sharlene G Rakoczy; Giulio Taglialatela; Holly M Brown-Borg; Colin K Combs
Journal:  Neurobiol Aging       Date:  2016-01-06       Impact factor: 4.673

9.  Early-onset GH deficiency results in spatial memory impairment in mid-life and is prevented by GH supplementation.

Authors:  E Nieves-Martinez; W E Sonntag; A Wilson; A Donahue; D P Molina; J Brunso-Bechtold; M M Nicolle
Journal:  J Endocrinol       Date:  2009-10-08       Impact factor: 4.286

Review 10.  Growth hormone and aging: a challenging controversy.

Authors:  Andrzej Bartke
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.